Unleashing the potential of natural biological peptide Macropin: Hydrocarbon stapling for effective breast cancer treatment

Bioorg Chem. 2023 Nov:140:106770. doi: 10.1016/j.bioorg.2023.106770. Epub 2023 Aug 16.

Abstract

The identification of novel candidate molecules with the potential to revolutionize the treatment of breast cancer holds profound clinical significance. Macropin (Mac)-1, derived from the venom of wild bees, emerges as an auspicious therapeutic agent for combating breast cancers. Nevertheless, linear peptides have long grappled with the challenges of traversing cell membranes and succumbing to protease hydrolysis. To address this challenge, the present study employed hydrocarbon stapling modification to synthesize a range of stapled Mac-1 peptides, which were comprehensively evaluated for their chemical and biological properties. Significantly, Mac-1-sp4 exhibited a remarkable set of improvements, including enhanced helicity, proteolytic stability, cell membrane permeability, induction of cell apoptosis, in vivo antitumor activity, and inhibition of tubulin polymerization. This study explores the significant impact of the hydrocarbon stapling technique on the secondary structure, hydrolase stability, and biological activity of Mac-1, shedding light on its potential as a revolutionary and potent anti-breast cancer therapy. The findings establish a strong basis for the development of innovative and highly effective anti-tumor treatments.

Keywords: Breast cancer; Macropin; Peptides; Stapling modification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Bees
  • Cell Membrane
  • Hydrocarbons
  • Neoplasms*
  • Peptide Hydrolases
  • Peptides* / pharmacology
  • Peptides* / therapeutic use

Substances

  • Peptides
  • Peptide Hydrolases
  • Hydrocarbons